← FDA Drug Approvals (Drugs@FDA)

DEFERASIROX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS ELIZABETH · Approved 2016-01-26

Drug application

FDA Application #

ANDA203560

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFERASIROX

Generic name

DEFERASIROX

Active ingredients

DEFERASIROX

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

ACTAVIS ELIZABETH

Manufacturer

Actavis Pharma, Inc.

First approval

2016-01-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown